Coronavirus / Johnson & Johnson claims - single dose vaccine is effective on every variant including Delta

Washington American Pharma Company Johnson & Johnson (Johnson & Johnson) has claimed that the single-dosage COVID-19 built compression (Anti Covid Vaccine) is effective against the delta (Delta) variants. Single DOZ vaccine was found 85% effect against severe or very serious illness. The company claims that it saved people from hospitalization and death. Blood samples of 8 people have been revealed that the vaccine delta is effective against all kinds of variants. J & J's Chief Scientific Officer Paul Stops said, "According to the study of the study that has been announced today, the vaccine of Johnson and Johnson is helpful to save the lives of people around the world. '

It was claimed that within 29 days of the vaccine's first dose neutralized Delta Variants. The company said that the effect of vaccine was similar to the global level including South Africa and Brazil. During studies, the cases of beta and zeta variants were being found in these areas. John Van Huf, another officer of J & J said, 'We are very happy. We are convinced that there is no need for this vaccine booster dose and it is effective on all variants. "

Based on the current figures, Howar said that the company believes that the people who have been vaccinated, will not need booster doses within a year. He said that even if needed, we do not think that the formulation will have to change.

Tell the Government of India is also talking about the issue of vaccine from Johnson and Johnson. Recently, Johnson and Johnson's Indian unit spokesman had told the news agency ANI, "According to DCGI's recent announcement, there is no need to fulfill the clinical studies of Corona-Practic View in India. We are discussing with the Government of India and find out how to increase our ability to give their single dosage vaccine in India.